ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
PFB63
|
23K |
13M |
4 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
PFB63
|
17K |
6.7M |
6 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
PFB63
|
23K |
13M |
9 |
17/05/20 |
17/05/20 |
ASX - By Stock
|
23K
|
13M
|
9
|
|
ASX - By Stock
|
CHN |
Re:
20
|
|
PFB63
|
30 |
703K |
0 |
17/05/20 |
17/05/20 |
ASX - By Stock
|
30
|
703K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast gets one more roll of the dice
|
|
PFB63
|
79 |
45K |
8 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
79
|
45K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
PFB63
|
933 |
436K |
18 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
933
|
436K
|
18
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Trading Halt
|
|
PFB63
|
195 |
93K |
3 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
195
|
93K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
$MESO Started Phase 2/3 Covid ARDS trial 3 days ago with 6 locations now expanded to 14!
|
|
PFB63
|
87 |
48K |
2 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
87
|
48K
|
2
|
|
ASX - By Stock
|
KLL |
Re:
Whats going on here
|
|
PFB63
|
72 |
38K |
4 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
72
|
38K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
PFB63
|
17K |
6.7M |
3 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
PFB63
|
23K |
13M |
5 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
PFB63
|
23K |
13M |
4 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
|
|
PFB63
|
188 |
78K |
11 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
188
|
78K
|
11
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
PFB63
|
23K |
13M |
17 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
23K
|
13M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
PFB63
|
17K |
6.7M |
5 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Gilead vs Mesoblast
|
|
PFB63
|
274 |
111K |
4 |
02/05/20 |
02/05/20 |
ASX - By Stock
|
274
|
111K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Gilead vs Mesoblast
|
|
PFB63
|
274 |
111K |
3 |
02/05/20 |
02/05/20 |
ASX - By Stock
|
274
|
111K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Gilead vs Mesoblast
|
|
PFB63
|
274 |
111K |
2 |
02/05/20 |
02/05/20 |
ASX - By Stock
|
274
|
111K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment
|
|
PFB63
|
296 |
99K |
6 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
296
|
99K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment
|
|
PFB63
|
296 |
99K |
0 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
296
|
99K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
PFB63
|
3.1K |
1.4M |
1 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
PFB63
|
3.1K |
1.4M |
6 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment
|
|
PFB63
|
296 |
99K |
2 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
296
|
99K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 2/3 Trial in COVID-19 ARDS Begins Enrollment
|
|
PFB63
|
296 |
99K |
26 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
296
|
99K
|
26
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
PFB63
|
23K |
13M |
7 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
23K
|
13M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
PFB63
|
17K |
6.7M |
2 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
PFB63
|
17K |
6.7M |
0 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
17K
|
6.7M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
PFB63
|
17K |
6.7M |
3 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
US Analyst update today
|
|
PFB63
|
7 |
2.7K |
3 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
7
|
2.7K
|
3
|
|